Please assess the completion status of the following clinical trial:

Trial Title: Comparison of 3 Diagnostic Strategies of PE: Planar V/Q Scan, CTPA, and V/Q SPECT.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Outpatients with a clinically suspected PE (defined as an acute onset of new or worsening shortness of breath, chest pain, hemoptysis, presyncope, or syncope) without another obvious apparent cause.~* High pretest clinical probability of PE or a non-high pretest clinical probability but a positive D-Dimer test.~Exclusion Criteria:~* Age less than 18 years~* Patients with already confirmed PE~* Patients with a clinically suspected high-risk pulmonary embolism (hypotension or shock)~* Use of therapeutic doses of anticoagulants for more than 48 hours~* Other indication for long-term use of anticoagulants~* Contraindication to contrast media (including renal insufficiency with a creatinine clearance lower than 30 ml/min)~* Life expectancy less than 3 months~* Unable/unwilling to give informed consent~* Unlikely to comply with study follow-up~* Ongoing pregnancy or breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Planar V/Q-based strategy (Type: ACTIVE_COMPARATOR): Control arm
- CTPA-based strategy (Type: ACTIVE_COMPARATOR): Control arm
- V/Q SPECT-based strategy (Type: EXPERIMENTAL): Experimental arm

Based on this trial design, predict the completion outcome and termination type (if applicable).